Glenmark Life Sciences Q2 Results
- BSE: 543322
- NSE: GLS
- ISIN: INE03Q201024
- Sector: Biotechnology & Drugs
BSE
1,097.55
48.65 (4.64%)
48.65 (4.64%)Volume13.13 K
Updated: Mon 25 Nov, 2024 | 15:29:08
NSE
1,092.6547.00 (4.49%)
47.00 (4.49%)Volume2.00 L
Updated: Mon 25 Nov, 2024 | 15:42:42
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹506.88 Cr.(-13.89%)
- Operating Profit₹119.27 Cr.(-17.80%)
- Profit After Tax₹95.32 Cr.(-14.50%)
- Operating Margin23.53%(-9.01%)
Note: Comparison is on YoY basis
Quarterly - Glenmark Life Sciences Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 506.88 | 578.45 | -% | 595.36 | -% |
| Selling/ General/ Admin Expenses Total | 62.44 | 48.13 | -% | 66.71 | -% |
| Depreciation/ Amortization | 15.09 | 12.61 | -% | 13.13 | -% |
| Other Operating Expenses Total | 84.89 | 89.12 | -% | 88.48 | -% |
| Total Operating Expense | 387.61 | 397.90 | -% | 441.41 | -% |
| Operating Income | 119.27 | 180.55 | -% | 153.95 | -% |
| Net Income Before Taxes | 127.46 | 182.00 | -% | 158.93 | -% |
| Net Income | 95.32 | 135.45 | -% | 118.74 | -% |
| Diluted Normalized EPS | 7.75 | 11.05 | -% | 9.69 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST